ClinicalTrials.gov
public full text
Public Domain
Does Abatacept Induce Regulatory B Cells in Patients With Rheumatoid Arthritis
Abatacept disrupts T-cell coactivation signals in rheumatoid arthritis (RA). Its potential effects on B cells are not well described. This study will assess the effects of abatacept therapy on the phenotype and function of peripheral blood B cells in patients with RA.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Characterization of Autoreactive b Lymphocytes in Autoimmune Diseases and Immune Deficiencies#841030
- A Phase III Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis#1045468
- A Study of Abatacept in Participants That Only Recently Started to Develop Rheumatoid Arthritis#162333
- Characterization of the Phenotypic Markers of B Cell Lymphocytes in Rheumatoid Arthritis#897953
- Functional and dysfunctional T regulatory cell states in human tissues in RA and other autoimmune arthritic diseases#485154
Record · ID 911150
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive